643 related articles for article (PubMed ID: 21606084)
21. New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function.
Zhang XH; Chen H; Siu CW; Yiu KH; Chan WS; Lee KL; Chan HW; Lee SW; Fu GS; Lau CP; Tse HF
J Cardiovasc Electrophysiol; 2008 Feb; 19(2):136-41. PubMed ID: 18005026
[TBL] [Abstract][Full Text] [Related]
22. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
[TBL] [Abstract][Full Text] [Related]
23. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation.
Orlov MV; Gardin JM; Slawsky M; Bess RL; Cohen G; Bailey W; Plumb V; Flathmann H; de Metz K
Am Heart J; 2010 Feb; 159(2):264-70. PubMed ID: 20152225
[TBL] [Abstract][Full Text] [Related]
24. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
[TBL] [Abstract][Full Text] [Related]
25. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
[TBL] [Abstract][Full Text] [Related]
26. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
[TBL] [Abstract][Full Text] [Related]
27. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
Brignole M; Pentimalli F; Palmisano P; Landolina M; Quartieri F; Occhetta E; Calò L; Mascia G; Mont L; Vernooy K; van Dijk V; Allaart C; Fauchier L; Gasparini M; Parati G; Soranna D; Rienstra M; Van Gelder IC;
Eur Heart J; 2021 Dec; 42(46):4731-4739. PubMed ID: 34453840
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
[TBL] [Abstract][Full Text] [Related]
29. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
[TBL] [Abstract][Full Text] [Related]
30. Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: follow-up study.
Petrac D; Radićc B; Radeljić V; Hamel D; Filipović J
Croat Med J; 2005 Dec; 46(6):929-35. PubMed ID: 16342346
[TBL] [Abstract][Full Text] [Related]
31. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
Bradley DJ; Shen WK
Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
[TBL] [Abstract][Full Text] [Related]
32. The European CRT Survey: 1 year (9-15 months) follow-up results.
Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K;
Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034
[TBL] [Abstract][Full Text] [Related]
33. Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation.
Brignole M; Gammage M; Puggioni E; Alboni P; Raviele A; Sutton R; Vardas P; Bongiorni MG; Bergfeldt L; Menozzi C; Musso G;
Eur Heart J; 2005 Apr; 26(7):712-22. PubMed ID: 15618036
[TBL] [Abstract][Full Text] [Related]
34. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
[TBL] [Abstract][Full Text] [Related]
35. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
[TBL] [Abstract][Full Text] [Related]
37. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
38. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods.
Ritter P; Delnoy PP; Padeletti L; Lunati M; Naegele H; Borri-Brunetto A; Silvestre J
Europace; 2012 Sep; 14(9):1324-33. PubMed ID: 22549295
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
